Fenofibrate and risk of minor amputations in diabetes.
Fazio
Sergio
S
Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA. Sergio.fazio@vanderbilt.edu
Linton
MacRae F
MF
D000671:Amputation, Surgical / Q000706:statistics & numerical data*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000517:prevention & control*; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D040242:Risk Reduction Behavior; D016896:Treatment Outcome; D014945:Wound Healing
D000960:Hypolipidemic Agents; D011345:Fenofibrate